Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of P-3058 (terbinafine) nail solution in paediatric onychomycosis
2013-005595-17Phase 3Completed
- Sponsor
- Polichem
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of terbinafine in onychomycosis, sponsored by Polichem. Primary endpoint: Local tolerability at application site. Started Jan 2014; status: completed.
02
Drugs
terbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2013-005595-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005595-17.